Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 May 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Yi Zhou123ACDE, Yantao Ding123BCDE, Mengxing Cui4F, Yuanjing Zhang123BCD, Mengwei Wang32B, Feiran Zhou5F, Yi Su6F, Bo Liang123ACDG*, Fusheng Zhou123ACD

DOI: 10.12659/MSM.943360

Med Sci Monit 2024; 30:e943360

Figure 3 Lipid metabolic alterations in patients with psoriasis after methotrexate (MTX) treatment(A) Principal component analysis plot clearly separating samples from 0 and 12 weeks of MTX treatment in cohort 1. (B) Volcano plot showing 139 differentially expressed metabolites. (C) Three representative lipids were significantly altered after 12 weeks of MTX treatment. Each dot indicates an individual. The 1 quantile and mean and 3 quantile levels are shown in the boxplot. (D) Metabolic pathways showed that the differentially expressed lipids are prominent in the glycerophospholipid pathway. (Figures were generated by R with ggplot2_3.4.2, EnhancedVolcano_1.16.0. The metabolic pathways analysis was based on MetaboAnalyst 6.0.).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750